PARP inhibitors and prostate cancer: What urologists need to know

Research output: Contribution to journal › Comment/debate › peer-review

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{7116577d7f8041f5a9de83b2bade7392,

title = "PARP inhibitors and prostate cancer: What urologists need to know",

author = "Antonarakis, \{Emmanuel S.\}",

year = "2021",

month = feb,

language = "English (US)",

volume = "49",

journal = "Urology Times",

issn = "0093-9722",

publisher = "Advanstar Communications Inc.",

number = "2",

}

TY - JOUR

T1 - PARP inhibitors and prostate cancer

T2 - What urologists need to know

AU - Antonarakis, Emmanuel S.

PY - 2021/2

Y1 - 2021/2

UR - https://www.scopus.com/pages/publications/85101751613

UR - https://www.scopus.com/pages/publications/85101751613#tab=citedBy

M3 - Comment/debate

AN - SCOPUS:85101751613

SN - 0093-9722

VL - 49

JO - Urology Times

JF - Urology Times

IS - 2

ER -